Monoclonal Antibody to Heat Shock 70kDa Protein 1 Like Protein (HSPA1L)
| Code | Size | Price |
|---|
| MAB062Ra22-20ul | 20ul | £92.00 |
Quantity:
| MAB062Ra22-100ul | 100ul | £173.00 |
Quantity:
| MAB062Ra22-200ul | 200ul | £235.00 |
Quantity:
| MAB062Ra22-1ml | 1ml | £542.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Mouse
Antibody Clonality: Monoclonal
Regulatory Status: RUO
Target Species: Rat
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Immunocytochemistry (ICC)
- Immunohistochemistry- Frozen Section (IHC-F)
- Immunohistochemistry- Paraffin Embedded (IHC-P)
- Western Blot (WB)
Documents
Further Information
Alternative Names:
HSP-A1L; HSPA1-L; HSP70-HOM; Hum70t
Buffer Formulation:
0.01M PBS, pH7.4, containing 0.01% Proclin-300, 50% glycerol.
Item Name:
Heat Shock 70kDa Protein 1 Like Protein
Potency (Clone Number):
1:270000 (6#)
Reactivity:
Hu;Mu;
Source:
Monoclonal antibody preparation
Usage:
Western blotting: 0.5-2ug/mL;1:130-500
Immunohistochemistry: 5-20ug/mL;1:13-50
Immunocytochemistry: 5-20ug/mL;1:13-50
Optimal working dilutions must be determined by end user.
Immunohistochemistry: 5-20ug/mL;1:13-50
Immunocytochemistry: 5-20ug/mL;1:13-50
Optimal working dilutions must be determined by end user.
Related Products
| Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recombinant Heat Shock 70kDa Protein 1 Like Protein (HSPA1L) | RPB062Ra01 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||